Temodex is a locally acting form of temozolomide developed by the Research Institute of Physical and Chemical Preparations at Belorussian State University in Minsk, Belarus, and has successfully been tested in clinical trials. Temodex is a gel that is locally administered in the cavity formed after resection of brain tumors. Thereby it can start to act against remaining tumor cells immediately after the removal of the tumor.
Use the products according to the recommendations written on the packages/patient information leaflets. Contact us if you have any questions about the products, complaints, or you want to report the side effects from any of our products:
Virdings Allé 32 B
754 50 Sverige